window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 2, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Cell Therapy

  • Advanced Therapies,Opinion & Events

    CAR T Vision coalition sets goal to double access to therapy by 2030

    A new international alliance, CAR T Vision, launched today with [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    ScaleReady awards multiple G-Rex grants to USC and Children’s Hospital of Los Angeles Investigators

    ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain

    CellProthera taps CELLforCURE by SEQENS for phase 3 production of heart attack cell therapy

    First clinical batches of ProtheraCytes expected in 2026 CellProthera has [...]

    May 5, 2026
  • Advanced Therapies

    GeneFab and RegCell partner to advance autoimmune Treg therapy toward US trials

    May 5, 2026
  • Advanced Therapies

    Astraveus teams up with NecstGen to trial benchtop CAR-T manufacturing platform

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business

    Cellevate consortium secures €1M Eurostars grant to boost iPSC manufacturing at scale

    May 5, 2026
  • Biotech & Pharma Business

    RoosterBio and Thermo Fisher team up to accelerate cell and exosome therapy manufacturing

    May 5, 2026
  • Advanced Therapies

    Cycuria Therapeutics launches with advisory board and major grant funding

    May 5, 2026
  • Advanced Therapies

    Cellevate, Fraunhofer IBMT, and OLS secure Eurostar grant to advance large-scale iPSC production

    Cellevate AB, Fraunhofer IBMT, and Omni Life Science (OLS) have [...]

    May 5, 2026
  • Biotech & Pharma Business

    Immunai and Parker Institute partner on landmark single-cell cancer dataset

    May 5, 2026
Previous567Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme
    Categories: Advanced Therapies, Biotech & Pharma Business, Research & Development
  • AstraZeneca advances oral COPD drug into Phase 2b trial
    Categories: Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Fuse Diagnostics raises £1M to scale rapid molecular testing platform
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Medical devices, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top